Raiffeisen Switzerland B.V. Share Price

Certificat

LTLRCH

CH1251119652

Market Closed - Swiss Exchange 16:20:00 20/06/2024 BST
100.9 CHF -1.23% Intraday chart for Raiffeisen Switzerland B.V.
1 month-0.14%
3 months-0.99%

Static data

Product typeObligations Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Raiffeisen Switzerland B.V.
LTLRCH
ISINCH1251119652
Date issued 17/03/2023
Strike 261.8 CHF
Maturity 17/12/2024 (164 Days)
Parity 0.26 : 1
Emission price 100 CHF
Emission volume N/A
Settlement les deux
Currency CHF

Technical Indicators

Highest since issue 103.2 CHF
Lowest since issue 98.69 CHF
Spread 8.1 CHF
Spread %0.80%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
243.3 CHF
Average target price
276.6 CHF
Spread / Average Target
+13.70%
Consensus
  1. Stock Market
  2. Certificates
  3. LTLRCH Certificat